As of May 10, 2021, Stark & Stark is no longer accepting inquiries for this litigation. For an updated list of our current cases, visit our homepage.
Pradaxa (dabigatran etexilate) is an FDA-approved blood thinner prescribed to patients to control atrial fibrillation (irregular heartbeat), deep vein thrombosis (DVT) and pulmonary embolus (PE).
Pradaxa has been widely prescribed, with millions of people taking the medication since it entered the market. Pradaxa is manufactured by Boehringer Ingelheim. Marketing efforts claim that Pradaxa is safer than warfarin (a traditional anticoagulant), but recent studies suggest otherwise.
Since its approval, there have been numerous reports of increased risk of uncontrollable bleeding and injury when taking Pradaxa, including: gastrointestinal (GI) bleeding, intracranial bleeding, hemorrhagic stroke, and, in some cases, death.
Thousands of claims against the makers of Pradaxa were consolidated into a Multidistrict Litigation (MDL) in the United States District Court for the Southern District of Illinois. In 2014, Boehringer Ingelheim settled roughly 4,000 of those claims for $650 million. Lawsuits are still moving forward in courts throughout the nation.
Stark & Stark’s Mass Tort team pursues claims against drug manufacturers so they can be held liable when the drugs they market are proven to be defective and cause injury to the people who use them. Our Pradaxa lawsuit lawyers are experienced in mass torts MDL litigation cases and in negotiating with pharmaceutical settlement representatives. If you or a member of your family has suffered an injury from Pradaxa use, you may be entitled to compensation.
Please contact Stark & Stark to speak with one of the Pradaxa attorneys, free of charge, who can help assess any claims that you may have and to help you understand the settlement and lawsuit process.
Stark & Stark Attorneys Recognized as New Jersey “Super Lawyers” and “Rising Stars” in 2026
Stark & Stark is pleased to announce that 15 of its attorneys have been selected for inclusion in the list of 2026 New Jersey Super Lawyers,...Bruce Stern, Esq. Secures $1,000,000 Settlement in Motor Vehicle Collision Case
Bruce Stern, Esq. recently secured a $1,000,000 settlement in a motor vehicle collision case.* “This case highlights how quickly things can go...Deborah Dunn, Esq. Elected to Board of Directors for Angel Flight East
Stark & Stark is pleased to announce that Deborah Dunn, Esq., Shareholder and Civil Trial Attorney, has been elected to the Board of Directors...Michael Jordan, Esq. Joins the Board of the Lawrence Township Community Foundation
It is our pleasure to announce that Michael Jordan, Esq. has joined the board of the Lawrence Township Community Foundation, an organization...Joseph Lemkin, Esq. Named to ROI-NJ Influencers: Power List 2026 – Law
Stark & Stark is proud to share that Joseph Lemkin, Esq., Shareholder, has been named to the 2026 Influencers: Power List in the Law category...Joseph Cullen, Esq. and Nicole Durso, Esq. Secure $2,000,000 Settlement in Personal Injury Matter
Joseph Cullen, Esq. and Nicole Durso, Esq. recently secured a $2,000,000 settlement in a personal injury matter involving a pedestrian who was struck...